Roquette Showcases Biopharma Innovations at CPhI Worldwide 2018
The provider of plant-based ingredients will present recently launched multi-compendial materials for upstream and downstream biopharmaceutical applications.
Roquette announced that it recently launched low endotoxin Kleptose BioPharma hydroxypropyl betacyclodextrin grades of hydroxypropyl β-cyclodextrins for protein stability and Dextrose Anhydrous BioPharma for cell-culture solutions for upstream and downstream biopharma applications.
According to the company, these solutions are supported by vertically integrated manufacturing, International Conference on Harmonization Q7 quality standards, and a fiber-free supply chain. Roquette recently expanded its research and development and customer technical service teams to include facilities in Singapore’s Biopolis international research and development center to develop these products.
“Now our deep expertise in formulation and applications science enables us to provide customers with even more localized project support around the world and in-depth training on-site,” Roquette stated in an Aug. 27, 2018 company press release. “Laboratory and pilot equipment at these facilities help customers address their technical and innovation challenges.”
Additionally, the company will also showcase recently acquired Microcrystalline Cellulose products and other excipients and hold 360-degree virtual experience recreation tours at stand 8F30 at CPhI in Madrid, Spain, taking place Oct. 9–11, 2018.
Source: Roquette
Thermo Fisher Opens Advanced Therapies Collaboration Center in California
April 18th 2025The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.
